Antithrombin Alfa Terminated Phase 4 Trials for Thrombophilia Due to Acquired Antithrombin III Deficiency Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01547728Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery